jamunjar-logo
whatsapp
cartmembermenu
Search for
"test & packages"
"physiotherapy"
"heart"
"lungs"
"diabetes"
"kidney"
"liver"
"cancer"
"thyroid"
"bones"
"fever"
"vitamin"
"iron"
"HTN"

Neck Mass Biopsy - XL

Biopsy
image

Report in 288Hrs

image

At Home

nofastingrequire

No Fasting Required

Details

Biopsies of neck masses.

₹888₹1,269

30% OFF

Neck Mass Biopsy -XL

  • Why is it done?
    • To obtain tissue samples from an abnormal mass or enlargement in the neck region for definitive histopathological diagnosis
    • To determine whether a neck mass is benign or malignant, including identification of cancerous cells
    • To identify the specific type of pathology (lymphoma, carcinoma, thyroid disease, infections, cysts, or benign tumors)
    • To guide treatment decisions and establish prognosis for patients with persistent or suspicious neck masses
    • Typically performed when imaging studies (ultrasound, CT, MRI) show an indeterminate or suspicious lesion that persists beyond 2-3 weeks
  • Normal Range
    • Normal Result (Negative): No malignant cells identified; tissue consistent with benign pathology, normal lymphoid tissue, or reactive inflammation
    • Benign Findings may include: Lymphoid hyperplasia, benign cysts, lipomas, fibromas, inflammatory conditions, or reactive lymph nodes
    • Non-Diagnostic Results: Insufficient tissue obtained; repeat biopsy may be recommended
    • Abnormal Result (Positive): Malignant cells present; specific diagnosis documented (squamous cell carcinoma, lymphoma, thyroid carcinoma, metastatic disease, etc.)
  • Interpretation
    • Benign Pathology: Indicates the mass is not cancerous; further imaging follow-up or clinical observation may be recommended depending on specific diagnosis
    • Malignant Pathology: Confirms cancer diagnosis; staging studies, oncology consultation, and treatment planning are urgently needed
    • Infectious Etiology: May identify specific organisms (bacteria, fungi, mycobacteria) requiring targeted antimicrobial therapy
    • Lymphoma Diagnosis: Specific subtype classification provided through immunophenotyping and molecular analysis; critical for treatment selection
    • Factors Affecting Results: Adequate tissue sampling, specimen fixation and handling, presence of necrotic material, crush artifact, or inflammation may affect interpretability
    • Ancillary Studies: Immunohistochemistry, flow cytometry, molecular testing, and HPV status may be performed to refine diagnosis and guide treatment
  • Associated Organs
    • Primary Organ Systems: Cervical lymph nodes, thyroid gland, salivary glands (parotid, submandibular, sublingual), and adjacent soft tissues of the neck
    • Lymphatic System: Cervical lymphadenopathy from lymphoma, metastatic cancer, reactive hyperplasia, or infection
    • Endocrine System: Thyroid nodules and thyroid cancer (papillary, follicular, medullary, anaplastic carcinoma)
    • Head and Neck Cancers: Squamous cell carcinoma, adenocarcinoma, and other primary malignancies
    • Metastatic Disease: Detection of cancer spread from lungs, breast, gastrointestinal tract, or other primary sites
    • Infectious Diseases: Tuberculosis, atypical mycobacteria, fungal infections, or chronic bacterial lymphadenitis
  • Follow-up Tests
    • If Malignancy Confirmed: PET-CT scan for staging, MRI neck for extent assessment, and chest/abdomen imaging to exclude metastatic disease
    • Oncology Consultation: For treatment planning including surgery, chemotherapy, radiation therapy, or immunotherapy
    • If Thyroid Pathology: Thyroid function tests (TSH, free T4), thyroid antibodies, and possible thyroidectomy or treatment planning
    • If Lymphoma Diagnosed: Complete blood count, lactate dehydrogenase (LDH), uric acid, and possible bone marrow biopsy for staging
    • If Infection Identified: Culture and sensitivity results to guide appropriate antimicrobial therapy and infectious disease consultation
    • If Benign Finding: Clinical follow-up or imaging surveillance at 2-4 weeks, or at 6-12 months depending on specific diagnosis
    • If Non-Diagnostic: Repeat biopsy with different technique (core needle, excisional), or radiologically-guided sampling
  • Fasting Required?
    • Fasting: No, fasting is not required for neck mass biopsy
    • Medication Considerations: If sedation is planned, follow nothing by mouth (NPO) guidelines per anesthesia requirements (typically 6 hours for food, 2 hours for clear liquids)
    • Anticoagulation Management: Continue warfarin, apixaban, dabigatran, and rivaroxaban as directed; consult physician regarding aspirin or clopidogrel discontinuation 3-5 days prior if required
    • Pre-Procedure Preparation: Inform provider of allergies, bleeding disorders, current medications, and any difficulty with anesthesia
    • Post-Procedure: Avoid strenuous activity for 24-48 hours; keep biopsy site clean and dry; apply ice packs as directed to reduce swelling
    • Recovery Time: Plan for 1-2 hours for the procedure; local anesthesia typically allows same-day discharge; sedation may require longer recovery period

How our test process works!

customers
customers